ACE2 and COVID-19: Therefore, diabetic patients not only experience a state of low ACE2 because of their condition but also present a characteristic ACE2 downregulation due to virus entrance, which could, among other factors, contribute to why those patients have a worse COVID-19 prognosis than non-diabetic patients.